Page 5 - Read Online

Hepatoma Research
CONTENTS

Topic: What More We Can Do on Hepatitis C?

Editorial

1 HCC incidence and recurrence after DAAs: new insights
Necati Örmeci
Hepatoma Res 2019;5:11 http://dx.doi.org/10.20517/2394-5079.2019.14

Opinion

2 Elimination of hepatitis from Pakistan by 2030: is it possible?
Yasir Waheed, Masood Siddiq
Hepatoma Res 2018;4:45 http://dx.doi.org/10.20517/2394-5079.2018.58

Review

3 Ablative techniques in hepatocellular carcinoma treatment
Ehsun Naeem, Shahab Abid
Hepatoma Res 2018;4:18 http://dx.doi.org/10.20517/2394-5079.2018.22

4 Molecular targeting of antiviral drugs used against hepatitis C virus infection
Mohammad Irshad, Priyanka Gupta, Khushboo Irshad
Hepatoma Res 2018;4:23 http://dx.doi.org/10.20517/2394-5079.2018.25

5 Epidemiology and viral risk factors for hepatocellular carcinoma in the Eastern Mediterranean
countries
Suna Yapali, Nurdan Tozun
Hepatoma Res 2018;4:24 http://dx.doi.org/10.20517/2394-5079.2018.57

6 Hepatitis C related hepatocellular carcinoma in the era of direct-acting antivirals
Akshata Moghe, Obaid S. Shaikh
Hepatoma Res 2018;4:36 http://dx.doi.org/10.20517/2394-5079.2018.54

7 Factors predicting hepatocellular carcinoma in hepatitis C infection
Zaigham Abbas, Minaam Abbas
Hepatoma Res 2018;4:43 http://dx.doi.org/10.20517/2394-5079.2018.26

8 Screening for hepatocellular carcinoma: summary of current guidelines up to 2018
Nevin Yilmaz, Ugur Eser Yilmaz, Kaya Suer, Vedat Goral, Nedim Cakir
Hepatoma Res 2018;4:46 http://dx.doi.org/10.20517/2394-5079.2018.49